Tata Nifty MidSmall Healthcare Index Fund
Direct · Growth ₹14.29
26 Oct 2026
NAV
11.6%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
0.74
Sharpe
-17.5%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
0.50%
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.58 L | 12.5% | -10.8% | 37.8% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 12.5% | 14.3% | 5.7% | -1.8% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 11.6% | 12.7% | -2.0% | 25.8% | 0.74 | 2.15 | 95% | — | — |
-17.5%
Max Drawdown
2 mo
Drawdown Duration
5 mo
Recovery Time
-4.1%
Avg Drawdown
Calmar Ratio by Duration
0.66
1Y
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +12.52 | 0.61 | 65.4% | 46.8% | 7.2% | -12.7% |
| 3 Years | +9.54 | 0.67 | 76.9% | 58.8% | 11.7% | -0.1% |
| 5 Years | +4.70 | 0.67 | 76.9% | 58.8% | 6.8% | -0.0% |
| 7 Years | +2.69 | 0.67 | 76.9% | 58.8% | 4.8% | -0.0% |
| 10 Years | +1.21 | 0.67 | 76.9% | 58.8% | 3.4% | -0.0% |
| 12 Years | +0.64 | 0.67 | 76.9% | 58.8% | 2.8% | -0.0% |
| 15 Years | +0.07 | 0.67 | 76.9% | 58.8% | 2.2% | -0.0% |
29
Total Holdings
60.2%
Top 10 Weight
3
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | LAURUS LABS LTD | 9.36% |
| 2 | LUPIN LTD | 9.30% |
| 3 | FORTIS HEALTHCARE LTD | 7.90% |
| 4 | AUROBINDO PHARMA LTD | 6.99% |
| 5 | GLENMARK PHARMACEUTICALS LTD | 5.26% |
| 6 | ALKEM LABORATORIES LTD | 5.17% |
| 7 | BIOCON LTD | 4.73% |
| 8 | MANKIND PHARMA LTD | 4.56% |
| 9 | IPCA LABORATORIES LTD | 3.74% |
| 10 | KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | 3.19% |